If you are interested in learning more about Longeveron or participating in a trial please fill out the form below or contact us.
Contact us
REPLAY AVAILABLE FROM OUR KOL EVENT
Click here to replay our KOL event, which was held on August 16, 2023, featuring Sunjay Kaushal, MD, PhD and Ram Kumar Subramanyan, MD, PhD, discussing the potential for Medicinal Signaling Cells (MSCs), such as those making up Longeveron’s Lomecel-B™ injection, to improve the outcome for Hypoplastic Left Heart Syndrome (HLHS) patients.